KATHRYN NEISLER: Open Payments
NPI 1508347154 · SHELBYVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,098 in 49 payments from 13 companies in 2025. Trend: 2023 $1,093 · 2024 $1,506 · 2025 $1,098
Food & beverage: $1,082Education: $16
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $356 |
| Novartis Pharmaceuticals Corporation | 17 | $217 |
| AstraZeneca Pharmaceuticals LP | 8 | $142 |
| Ionis Pharmaceuticals, Inc. | 1 | $106 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $73 |
| Corcept Therapeutics | 2 | $43 |
| BridgeBio Pharma, Inc. | 2 | $39 |
| Medtronic, Inc. | 1 | $34 |
| Amgen Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $20 |
Products named: LEQVIO, Ozempic, FARXIGA, Wegovy, JARDIANCE, Korlym, Attruby, VENASEAL.
Industry payments across IN — which companies pay providers there.
